Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Esperovax Logo
Esperovax Growth Score
46
CB Rank
65050
Heat Score
70
Esperovax is a biotechnology company based in Plymouth, MI.
Founded
obfuscation
PrivateGrant Plymouth, Michigan, United States11-50 esperovax.com
Biotechnology
Overview

Esperovax
Total Funding
obfuscation
Growth Score
46
Heat Score
70

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score46
-4 pts
in past quarter
Heat Score 70
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Esperovax

CB Rank
65050
Esperovax is a biotechnology company based in Plymouth, MI.
Founded
obfuscation
PrivateGrant Plymouth, Michigan, United States11-50 esperovax.com
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Esperovax, Inc.
Operating Status Active
Company Type For Profit
Founders  David O'Hagan, Roger S. Newton, Savita Nikam
About the Company
Esperovax is a biotechnology company specializing in a unique, proprietary platform that produces and delivers targeted mRNA oral biologic medicines.
Contact Email info@esperovax.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Products & Services

Egress™ oral biologics platform
A platform for developing oral mRNA vaccines aimed at preventing and treating infections in humans and animals.
COVID-19 Oral mRNA Vaccine
An oral vaccine targeting COVID-19, utilizing mRNA technology for immune system activation against virus strains.

Research & Development

Esperovax is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant
obfuscation
Grant - Esperovax Logo
Grant - Esperovax
1
obfuscation
BLUE KNIGHTGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
BLUE KNIGHT Logo
BLUE KNIGHT
Yes
Grant - Esperovax Logo
Grant - Esperovax
—
BLUE KNIGHT Logo
BLUE KNIGHT
Yes
Grant - Esperovax Logo
Grant - Esperovax
—
BLUE KNIGHT Logo
BLUE KNIGHT
Yes
Grant - Esperovax Logo
Grant - Esperovax
—
BLUE KNIGHT Logo
BLUE KNIGHT
Yes
Grant - Esperovax Logo
Grant - Esperovax
—
BLUE KNIGHT Logo
BLUE KNIGHT
Yes
Grant - Esperovax Logo
Grant - Esperovax
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Dec 13, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 12, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 1, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 1, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$90.8KThis year, Esperovax is projected to spend $90.8K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Amazon (AMZN) Logo
Amazon (AMZN)
74

Active Website Tech Count

5Esperovax is actively using 5 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.

Total IP

4The intellectual property of Esperovax includes 4 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Esperovax's headquarters? Esperovax is located in Plymouth, Michigan, United States.Who invested in Esperovax? Esperovax has 3 investors including BLUE KNIGHT and  Michigan Rise.When was the last funding round for Esperovax? Esperovax closed its last funding round on
obfuscation
from a Grant round.Who are Esperovax's competitors? Alternatives and possible competitors to Esperovax may include Vaxart, Oramed Pharmaceuticals, and  Dynavax Technologies.How much funding has Esperovax raised to date? Esperovax has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|